Alcohol Drinking Patterns and the Risk of Fatty Liver in Japanese Men

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2010 Oct 23

PMID 20967556

Citations 22

Authors

Yasunari Hiramine

Yasushi Imamura

Hirofumi Uto

Chihaya Koriyama

Masahisa Horiuchi

Makoto Oketani

Kaori Hosoyamada

Ken Kusano

Akio Ido

Hirohito Tsubouchi

Affiliations

Soon will be listed here.

Abstract

Background: Alcohol is considered to be a major cause of fatty liver (FL). In contrast, however, recent investigations have suggested that moderate alcohol consumption is protective against FL. To clarify the role of alcohol consumption in FL development, we examined the association between drinking patterns and FL prevalence.

Methods: We enrolled 9,886 male participants at regular medical health checks. Each subject's history of alcohol consumption was determined by questionnaire. The subjects were classified according to alcohol consumption as non-, light, moderate, and heavy drinkers (0, <20, 20-59, and ≥60 g/day, respectively). FL was defined by ultrasonography. Independent predictors of FL were determined by logistic regression analysis.

Results: The prevalence of FL displayed a "U-shaped curve" across the categories of daily alcohol consumption (non-, 44.7%; light, 39.3%; moderate, 35.9%; heavy drinkers, 40.1%; P < 0.001). The prevalence of FL was associated positively with body mass index and other obesity-related diseases and inversely with alcohol consumption (light, odds ratio [OR] 0.71, 95% confidence interval [CI] 0.59-0.86; moderate, OR 0.55, CI 0.45-0.67; heavy, OR 0.44, CI 0.32-0.62) as determined by multivariate analysis after adjusting for potential confounding variables. In addition, examination of drinking patterns (frequency and volume) revealed that the prevalence of FL was inversely associated with the frequency of alcohol consumption (≥21 days/month) (OR 0.62, CI 0.53-0.71) but not with the volume of alcohol consumed.

Conclusions: Our observations suggest that alcohol consumption plays a protective role against FL in men, and consistent alcohol consumption may contribute to this favorable effect.

Citing Articles

Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.

Hagstrom H, Hegmar H, Moreno C United European Gastroenterol J. 2024; 12(2):168-176.

PMID: 38381115 PMC: 10954435. DOI: 10.1002/ueg2.12524.

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.

Diaz L, Arab J, Louvet A, Bataller R, Arrese M Nat Rev Gastroenterol Hepatol. 2023; 20(12):764-783.

PMID: 37582985 DOI: 10.1038/s41575-023-00822-y.

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.

Odriozola A, Santos-Laso A, Del Barrio M, Cabezas J, Iruzubieta P, Arias-Loste M Int J Mol Sci. 2023; 24(9).

PMID: 37175497 PMC: 10178387. DOI: 10.3390/ijms24097791.

Alcohol and Metabolic-associated Fatty Liver Disease.

Sun F, Wang B J Clin Transl Hepatol. 2021; 9(5):719-730.

PMID: 34722187 PMC: 8516839. DOI: 10.14218/JCTH.2021.00173.

Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?.

Protopapas A, Cholongitas E, Chrysavgis L, Tziomalos K Ann Gastroenterol. 2021; 34(4):476-486.

PMID: 34276185 PMC: 8276351. DOI: 10.20524/aog.2021.0641.

References

Sanal M . The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol. 2008; 14(6):831-44. PMC: 2687050. DOI: 10.3748/wjg.14.831. View

Imamura Y, Kobayashi K, Shibatou T, Aburada S, Tahara K, Kubozono O . Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res. 2003; 26(1):68-72. DOI: 10.1016/s1386-6346(02)00331-5. View

You M, Crabb D . Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G1-6. DOI: 10.1152/ajpgi.00056.2004. View

Hui J, Hodge A, Farrell G, Kench J, Kriketos A, George J . Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology. 2004; 40(1):46-54. DOI: 10.1002/hep.20280. View

Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N . Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008; 38(11):1122-9. DOI: 10.1111/j.1872-034X.2008.00382.x. View

Mukamal K, Conigrave K, Mittleman M, Camargo Jr C, Stampfer M, Willett W . Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003; 348(2):109-18. DOI: 10.1056/NEJMoa022095. View

Saheki T, Kobayashi K . Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet. 2002; 47(7):333-41. DOI: 10.1007/s100380200046. View

Kitajima Y, Eguchi Y, Ishibashi E, Nakashita S, Aoki S, Toda S . Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol. 2009; 45(2):218-24. DOI: 10.1007/s00535-009-0147-2. View

Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M . Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology. 2009; 50(3):772-80. DOI: 10.1002/hep.23094. View

10.

Dixon J, Bhathal P, OBrien P . Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121(1):91-100. DOI: 10.1053/gast.2001.25540. View

11.

Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R . Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006; 41(5):462-9. DOI: 10.1007/s00535-006-1790-5. View

12.

Davies M, Baer D, Judd J, Brown E, Campbell W, Taylor P . Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002; 287(19):2559-62. DOI: 10.1001/jama.287.19.2559. View

13.

Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M . Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2009; 45(1):86-94. DOI: 10.1007/s00535-009-0128-5. View

14.

Dunn W, Xu R, Schwimmer J . Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology. 2008; 47(6):1947-54. PMC: 6658188. DOI: 10.1002/hep.22292. View

15.

Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T, Heine R . Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2003; 27(1):184-9. DOI: 10.2337/diacare.27.1.184. View

16.

Wei M, Gibbons L, Mitchell T, Kampert J, Blair S . Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care. 2000; 23(1):18-22. DOI: 10.2337/diacare.23.1.18. View

17.

You M, Fischer M, Deeg M, Crabb D . Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002; 277(32):29342-7. DOI: 10.1074/jbc.M202411200. View

18.

Gaziano J, Buring J, Breslow J, Goldhaber S, Rosner B, VanDenburgh M . Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993; 329(25):1829-34. DOI: 10.1056/NEJM199312163292501. View

19.

Zhou Z, Wang L, Song Z, Lambert J, McClain C, Kang Y . A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol. 2003; 163(3):1137-46. PMC: 1868249. DOI: 10.1016/s0002-9440(10)63473-6. View

20.

Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y . Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men. Hepatol Res. 2008; 38(11):1083-6. DOI: 10.1111/j.1872-034X.2008.00383.x. View